期刊
NUCLEIC ACIDS RESEARCH
卷 32, 期 12, 页码 3743-3751出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkh691
关键词
-
资金
- NCI NIH HHS [R01 CA043322, CA77693, R01 CA077693, CA43322] Funding Source: Medline
For cells on the path to carcinogenesis, the key to unlimited growth potential lies in overcoming the steady loss of telomeric sequence commonly referred to as the 'end-replication problem' that occurs with each cell division. Most human tumors have reactivated telomerase, a specialized reverse transcriptase, that directs RNA-templated addition of telomeric repeats on to chromosomal termini. However, similar to10% of tumors maintain their telomeres through a recombination-based mechanism, termed alternative lengthening of telomeres or ALT. Here we demonstrate that telomeric DNA undergoes a high rate of a particular type of recombination visualized cytogenetically as sister chromatid exchange (SCE), and that this rate is dependent on genotype. A novel model of ALT is presented in which it is argued that telomeric exchanges, if they are unequal and occur at a sufficiently high frequency, will allow cells to proliferate indefinitely without polymerase-mediated extension of telomeric sequence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据